DRUG · Mapped RxNorm record
Ivabradine
Normalized identity: ivabradineView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Effect of Ivabradine in Stage D HF/Cardiogenic Shock Patients on Dobutamine
NCT03387605
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEffect of Ivabradine in Stage D HF/Cardiogenic Shock Patients on Dobutamine
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Heart Failureverified · MONDO: heart failure
Cardiogenic Shockverified · MONDO: cardiogenic shock
Tachycardiaunresolved
Interventions
IvabradineDRUG · verified · RxNorm: ivabradine
PlaceboDRUG
Sponsors & collaborators
Loyola Universitylead sponsor
Amgencollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03387605 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.